The DOI matches its Crossref record.
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Abstract
OBJECTIVE: To determine the effectiveness of vitamin E treatment in normalizing retinal blood flow and renal function in patients with <10 years of type 1 diabetes. RESEARCH DESIGN AND METHODS: An 8-month randomized double-masked placebo-controlled crossover trial evaluated 36 type 1 diabetic and 9 nondiabetic subjects. Subjects were randomly assigned to either 1,800 IU vitamin E/day or placebo for 4 months and followed, after treatment crossover, for a further 4 months. Retinal blood flow was measured using video fluorescein angiography, and renal function was assessed using normalized creatinine clearance from timed urine collections. RESULTS: After vitamin E treatment, serum levels of vitamin E were significantly elevated (P<0.01) in both type 1 diabetic and control patients. Hemoglobin A1c was not affected by vitamin E treatment. Diabetic patient baseline retinal blood flow (29.1+/-7.5 pixel2/s) was significantly (P = 0.030) decreased compared with that of nondiabetic subjects (35.2+/-7.2 pixel2/s). After vitamin E treatment, diabetic patient retinal blood flow (34.5+/-7.8 pixel2/s) was significantly increased (P<0.001) and was comparable with that of nondiabetic subjects. Additionally, vitamin E treatment significantly (P = 0.039) normalized elevated baseline creatinine clearance in diabetic patients. CONCLUSIONS: Oral vitamin E treatment appears to be effective in normalizing retinal hemodynamic abnormalities and improving renal function in type 1 diabetic patients of short disease duration without inducing a significant change in glycemic control. This suggests that vitamin E supplementation may provide an additional benefit in reducing the risks for developing diabetic retinopathy or nephropathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, vitamin E treatment significantly normalized elevated creatinine clearance in patients with diabetes 1.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Bursell et al. 1999
In the citing paper
“The results have shown that the serum level of vitamin E was significantly increased in both type 1 diabetic and control subjects. Glycated hemoglobin A1c (HbA1c) was improved by the vitamin E supply.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Bursell et al. 1999
In the citing paper
“Retina blood flow was evaluated using fluorescein angiography and was significantly lower compared to that of non-diabetic subjects. After treatment with vitamin E retina blood flow significantly increased in the group of diabetic patients and reached the level of non-diabetic subjects.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Bursell et al. 1999
Citations
Cited by
Sorted by citations
Items 101–200 of 333
Diabetic retinopathy: Pathogenic mechanisms and current treatments
Chistiakov, D. A. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.02.025 · Cited by 70
Vitamin E, Its Beneficial Role in Diabetes Mellitus (DM) and Its Complications
Jain, A. (2012) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2012/4791.2625 · Cited by 71
Horio, N., Clermont, A. C., Abiko, A., Abiko, T., Shoelson, B., Bursell, S., & Feener, E. P. (2004) · Diabetologia · doi:10.1007/s00125-003-1262-x · Cited by 71
“Previous studies have shown that treatment of DM rats with an endothelin type A receptor antagonist (BQ123), a PKCβ inhibitor (LY333531), or vitamin E could also ameliorate RBF abnormalities [10, 27, 30, 31].”
BackgroundSelf-citationPharmacotherapy for diabetic retinopathy
Comer, G. M., & Ciulla, T. A. (2004) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000143685.60479.3b · Cited by 71
Antioxidant activity of three extracts of Morus nigra
Naderi, G. A., Asgary, S., Sarrafzadegan, N., et al. (2004) · Phytotherapy Research · doi:10.1002/ptr.1400 · Cited by 70
“Antioxidant supplementation has also documented normalizing retinal haemodynamic abnormalities and improving renal function in type 1 diabetic patients of short disease duration (Bursell et al., 1999).”
BackgroundUpdate on the treatment of diabetic retinopathy.
Yam, J. C. S., & Kwok, A. K. (2007) · PubMed · Cited by 76
Delayed Treatment with Lithospermate B Attenuates Experimental Diabetic Renal Injury
Lee, G. T., Ha, H., Jung, M., Li, H., Hong, S. W., Soo, B., Lee, H. C., & Cho, A. Y. D. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051660.82593.19 · Cited by 69
García‐Medina, J. J., Rubio-Velázquez, E., Foulquie-Moreno, E., Casaroli-Marano, R. P., Pinazo-Duran, M. D., Zanón‐Moreno, V., & del‐Río‐Vellosillo, M. (2020) · Antioxidants · doi:10.3390/antiox9060561 · Cited by 69
“The authors reported that diabetic patients showed a decreased retinal blood flow that improved after treatment, similarly to control cases [134].”
Background15 th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes
Mario, U. D., & Pugliese, G. (2001) · Diabetologia · doi:10.1007/s001250051676 · Cited by 68
Aruoma, O. I., Neergheen, V. S., Bahorun, T., & Jen, L. (2006) · Neuroembryology and Aging · doi:10.1159/000109344 · Cited by 67
“ROS has been involved in decreased retinal blood flow [”
BackgroundPaul, M. V. S., Abhilash, M., Varghese, M. V., et al. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.714008 · Cited by 66
“α-tocopherol supplementation has improved renal function in type I diabetic patients and prevent oxidative stress related chronic renal failure in patients undergoing hemodialysis and nephropathy in rats (Bursell et al. 1999; Bhogade et al. 2008; Naziroglu et al. 2004).”
Lee, E. Y., Lee, E. Y., Hong, S. W., Chung, C. H., & Hong, S. Y. (2007) · Yonsei Medical Journal · doi:10.3349/ymj.2007.48.5.847 · Cited by 65
The role of protein kinase C in the development of the complications of diabetes
Ways, D. K., & Sheetz, M. J. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)60019-5 · Cited by 65
Asbaghi, O., Nazarian, B., Yousefi, M., Anjom-Shoae, J., Rasekhi, H., & Sadeghi, O. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00840-1 · Cited by 68
“In terms of types of diabetes, 7 studies included patients with type 1 diabetes [7, 46, 52, 53, 55, 56, 59], 3 studies recruited patients with diabetic nephropathy [14, 17, 29], one study perform the intervention on patients with diabetic neuropathy [15], and 26 studies enrolled type 2 diabetic patients.”
BackgroundInfluentialValidation of structural and functional lesions of diabetic retinopathy in mice.
Kern, T. S., Tang, J., & Berkowitz, B. A. (2010) · PubMed · Cited by 65
Biochemical Pathways for Microvascular Complications of Diabetes Mellitus
Setter, S. M., Campbell, R. K., & Cahoon, C. J. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d002 · Cited by 66
Agrawal, S. S., Naqvi, S., Gupta, S. K., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.05.057 · Cited by 64
“Oxidative stress caused by formation of free radicals leads to retinal vasculature damage (Bursell and King, 1999; Bursell et al., 1999).”
BackgroundValero-Velló, M., Peris‐Martínez, C., García‐Medina, J. J., Sanz-Gonzalez, S. M., Ramirez, A. I., Fernández‐Albarral, J. A., Galarreta, D., Zanón‐Moreno, V., Casaroli-Marano, R. P., & Pinazo-Duran, M. D. (2021) · Foods · doi:10.3390/foods10061231 · Cited by 68
“[164] investigated the supplementation with high-dose of α-tocopherol in a group of type-1 diabetes mellitus patients and found an increase of retinal blood flow that improved after 8-month supplementation.”
BackgroundThe Antioxidant Vitamins C and E
Packer, L. (2003) · AOCS Publishing eBooks · doi:10.4324/9780429270710 · Cited by 59
Role of oxidative stress in hearing impairment in patients with type two diabetes mellitus
Aladağ, İ., Eyibilen, A., Güven, M., Atış, Ö., & ERKOKMAZ, Ü. (2009) · The Journal of Laryngology & Otology · doi:10.1017/s0022215109004502 · Cited by 59
Beyond AREDS: Is There a Place for Antioxidant Therapy in the Prevention/Treatment of Eye Disease?
Kowluru, R. A., & Zhong, Q. P. W. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6768 · Cited by 57
“Furthermore, oral vitamin E administration increases retinal blood flow and normalizes hemodynamic abnormalities in the retina of diabetic patients.(89) In contrast, others have found no significant associations between serum levels of major dietary antioxidants and retinopathy.”
BackgroundSheu, M., Ho, F. M., Chao, K. F., Kuo, M. L., & Liu, S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.187 · Cited by 57
“…HG-induced extracellular matrix protein synthesis in mesangial cells (Trachtman, 1994) and in experimental diabetic animals (Koya et al., 1997), and that vitamin E normalized glomerular hyperfiltration in human diabetes (Bursell et al., 1999), revealed a pathogenic role of ROS in diabetes.”
Leo, M. A. S. D., Ghirlanda, G., Silveri, N. G., et al. (2003) · Free Radical Research · doi:10.1080/1071576021000055271 · Cited by 57
Tanito, M., Yoshida, Y., Kaidzu, S., Chen, Z., Cynshi, O., Jishage, K., Niki, E., & Ohira, A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0872 · Cited by 57
Millen, A. E. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg116 · Cited by 56
Riboflavin Alleviates Cardiac Failure in Type I Diabetic Cardiomyopathy
Wang, G., Li, W., Lu, X., & Zhao, X. (2011) · Heart International · doi:10.4081/hi.2011.e21 · Cited by 54
Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy
Ramsey, D. J., & Arden, G. B. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0686-2 · Cited by 55
Miao, X., Sun, W., Miao, L., Fu, Y., Wang, Y., Su, G., & Liu, Q. (2013) · Journal of Diabetes Research · doi:10.1155/2013/425854 · Cited by 59
Diabetic Retinopathy: Current Management and Experimental Therapeutic Targets
Ali, T. K., & El‐Remessy, A. B. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.2.182 · Cited by 53
Transition metals redox: reviving an old plot for diabetic vascular disease
Monnier, V. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12635 · Cited by 54
“In the diabetic human, conversely, while intra-arterial infusion of vitamin C improved endothelium-dependent vasodilation (1) and oral intake of vitamin E improved retinal blood flow and creatinine clearance (2), chronic treatment with vitamin E did not reduce cardiovascular risk (3).”
BackgroundThe Use of Vitamin E in Type 2 Diabetes Mellitus
Fardoun, R. Z. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701361601 · Cited by 54
Jialal, I., Devaraj, S., Huet, B., & Traber, M. G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90191-5 · Cited by 53
Afshari, M., Larijani, B. A., Rezaie, A. R., Mojtahedi, A., Zamani, M. J., Astanehi-Asghari, F., Mostafalou, S., Hossein‐Nezhad, A., Heshmat, R., & Abdollahi, M. R. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.09.012 · Cited by 49
EFSA Panel on Dietetic Products, N. A. A. (. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1816 · Cited by 51
High Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress
Zhao, Y., Zhang, W., Jia, Q., Feng, Z.-D., Guo, J., Han, X.-T., Liu, Y., Shang, H., Wang, Y.-X., & Liu, W.-J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01939 · Cited by 43
Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
Lü, L., Jiang, Y., Jaganathan, R., & Hao, Y. (2018) · Journal of Ophthalmology · doi:10.1155/2018/1694187 · Cited by 53
Clermont, A. C., Bursell, S., & Feener, E. P. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000220410.69116.f8 · Cited by 49
Self-citationAntioxidants and Diabetic Retinopathy
Williams, M. A., Hogg, R. E., & Chakravarthy, U. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0384-x · Cited by 49
Agardh, C., Stenram, U., Torffvit, O., et al. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00164-2 · Cited by 49
Antioxidants in the Prevention and Treatment of Diabetic Retinopathy – A Review
Baptista-Silva, S., da Costa, J. P. O., Pintado, M., Ferreira, D. D. C., & Sarmento, B. F. C. C. (2010) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000111 · Cited by 48
Calcium Dobesilate in the Treatment of Diabetic Retinopathy
Garay, R. P., Hannaert, P. A., & Chiavaroli, C. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504040-00003 · Cited by 45
The Potential Use of Glutathionyl Hemoglobin as a Clinical Marker of Oxidative Stress
Bursell, S., & King, G. L. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.2.145 · Cited by 45
Self-citationDiabetic macular edema: classification, medical and laser therapy
Bandello, F. M., Pognuz, D. R., Polito, A., et al. (2003) · Seminars in Ophthalmology · doi:10.1080/08820530390895262 · Cited by 44
Novel therapeutic approaches for diabetic nephropathy and retinopathy
Usuelli, V., & Rocca, E. L. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.10.003 · Cited by 44
Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms
Hernández, C., Simó-Servat, A., Bogdanov, P. M., & Simó, R. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0648-4 · Cited by 42
Edwards, G., Olson, C. G., Euritt, C. P., & Koulen, P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.890021 · Cited by 49
Effect of lipoic acid on expression of angiogenic factors in diabetic rat retina
Lee, S. G., Lee, C.-G., Yun, I. H., Hur, D. Y., Yang, J. W., & Kim, H. W. (2011) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02695.x · Cited by 41
Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy
Alfonso-Muñoz, E. A., Matas, R. B.-S. D. L., Mataix, J., Martín, J. C. M., & Desco, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084020 · Cited by 40
“utilised fluorescein angiography to analyse the retinal blood flow in T1DM patients, and they observed a significant increase in the Vitamin E-supplemented group [157].”
BackgroundMethodInfluentialAdjuvant strategies for prevention of glomerulosclerosis
McCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2004.11.048 · Cited by 38
Oxidative Stress As A Common Mediator for Apoptosis Induced-Cardiac Damage in Diabetic Rats
Dallak, M. A., Mikhailidis, D. P., Haidara, M. A., Bin‐Jaliah, I., Tork, O. M., Rateb, M., Yassin, H. Z., Al-refaie, Z. A., Ibrahim, I. M., Elawa, S. M., et al. (2008) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192400802010070 · Cited by 39
“On another level, antioxidant administration has been reported to show beneficial effects on parameters of oxidative stress and cardiovascular functions in experimental diabetes [17].”
BackgroundDiabetic retinopathy: a review
Chu, J., & Ali, Y. A. (2008) · Drug Development Research · doi:10.1002/ddr.20222 · Cited by 38
Tachikawa, M., Okayasu, S., & Hosoya, K.-I. (2007) · PubMed · Cited by 37
Giannini, C., Lombardo, F., Currò, F., Pomilio, M., Bucciarelli, T., Chiarelli, F., & Mohn, A. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.717 · Cited by 36
“had a considerably shorter duration of diabetes compared to the patients in our study [26].”
BackgroundMethodResultInfluentialBeneficial and adverse effects of vitamin E on the kidney
Baltušnikienė, A., Stanevičienė, I., & Jansen, E. H. J. M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1145216 · Cited by 38
Role of dietary antioxidants in diabetes: An overview
Shafras, M., Sabaragamuwa, R., & Suwair, M. (2024) · Food Chemistry Advances · doi:10.1016/j.focha.2024.100666 · Cited by 46
Association between dietary antioxidants and risk for diabetic retinopathy in a Chinese population
She, C., Shang, F., Cui, M., Yang, X., & Liu, N. (2020) · Eye · doi:10.1038/s41433-020-01208-z · Cited by 34
Chiarelli, F., Santilli, F., Sabatino, G., Blasetti, A., Tumini, S., Cipollone, F., Mezzetti, A., & Verrotti, A. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000141990.12375.13 · Cited by 32
Fujita, H., Narita, T., Meguro, H., et al. (2000) · Renal Failure · doi:10.1081/jdi-100100889 · Cited by 32
Kim, Y. H., Park, S. Y., Park, J., Kim, Y. S., Hwang, E., Park, J., Roh, G. S., Kim, H. J., Kang, S. S., Cho, G. J., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2625-y · Cited by 32
Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss
Sharma, Y., Saxena, S., Mishra, A., Saxena, A., & Natu, S. M. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1406-2 · Cited by 32
Emerging drugs for diabetic retinopathy
Mohamed, Q. A., & Wong, T. Y. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802584035 · Cited by 31
Natural products for the management of type 2 diabetes mellitus and comorbid conditions
Smith, J. D., & Clinard, V. B. (2014) · Journal of the American Pharmacists Association · doi:10.1331/japha.2014.14537 · Cited by 30
Schmidt-Erfurth, U. M. (2004) · KARGER eBooks · doi:10.1159/000082772 · Cited by 29
Superoxide dismutase overexpression and cellular oxidative damage in diabetes
Jain, S. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.07.017 · Cited by 28
Effect of Tempol on Diabetes-Induced Decreases in Retinal Blood Flow in the Mouse
Yadav, A. S., & Harris, N. R. (2011) · Current Eye Research · doi:10.3109/02713683.2011.556300 · Cited by 27
von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
Feng, D., Bursell, S., Clermont, A., et al. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1694 · Cited by 27
Self-citationEffect of High Glucose on Superoxide in Human Mesangial Cells: Role of Angiotensin II
Leehey, D. J., Isreb, M. A., Marcic, S. M., Singh, A. K., & Singh, R. (2005) · Nephron Experimental Nephrology · doi:10.1159/000084348 · Cited by 25
Aiello, L. P., Cahill, M. T., & Cavallerano, J. D. (2004) · Eye · doi:10.1038/sj.eye.6700585 · Cited by 24
Self-citationChanging Times for the Management of Diabetic Retinopathy
Fong, D. S. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00389-2 · Cited by 23
The vascular endothelium in diabetes: a practical target fordrug treatment?
Andrews, K. L., Pannirselvam, M., Anderson, T. J., Jenkins, A. J., Triggle, C. R., & Hill, M. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.101 · Cited by 23
“Studies in human Type 1 diabetes (in young complication-free subjects) using surrogate end points of retinal blood flow [134] and flow-mediated dilation [125] and high-dose vitamin E have been positive.”
BackgroundTanito, M., Itoh, N., Yoshida, Y., et al. (2004) · Lipids · doi:10.1007/s11745-004-1252-0 · Cited by 23
Extending Classification Algorithms to Case-Control Studies
Stanfill, B., Reehl, S., Bramer, L., Nakayasu, E. S., Rich, S. S., Metz, T., Rewers, M., Webb‐Robertson, B., & TEDDY Study Group (2019) · Biomedical Engineering and Computational Biology · doi:10.1177/1179597219858954 · Cited by 20
Antioxidants for adults with chronic kidney disease
Colombijn, J. M. T., Hooft, L., Jun, M., Webster, A. C., Bots, M. L., Verhaar, M. C., & Vernooij, R. W. M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008176.pub3 · Cited by 23
Beyazyıldız, E., Çankaya, A. B., Ergan, E., et al. (2013) · PubMed · doi:10.3980/j.issn.2222-3959.2013.04.23 · Cited by 22
OPHTHALMOLOGIC EMERGENCIES IN THE PATIENT WITH DIABETES
Wipf, J. E., & Paauw, D. S. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70166-3 · Cited by 22
Rassu, G., Pavan, B., Mandracchia, D., Tripodo, G., Botti, G., Dalpiaz, A., Gavini, E., & Giunchedi, P. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102286 · Cited by 26
Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review
Milluzzo, A., Barchitta, M., Maugeri, A., Lio, R. M. S., Favara, G., Mazzone, M. G., Sciacca, L., & Agodi, A. (2022) · Nutrients · doi:10.3390/nu14204430 · Cited by 23
“, 1999 [33] USA T1D NDR (36) HC (9) Vitamin E 1800 IU 4 months treatment + 4 months placebo DM patient retinal blood flow increased and was comparable with that of HC subjects.”
BackgroundResultInfluentialLi, L., Wang, H., Pang, S., Wang, L., Fan, Z., Ma, C., Yang, S., Banda, J., Hui, Q., Lv, F., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105127 · Cited by 22
“DHE was used for the detection of ROS.”
BackgroundInfluentialVascular Complications in Diabetes
Rosen, P., Tritschler, H., & Packer, L. (2001) · CRC Press eBooks · doi:10.1201/9780203904046.ch25 · Cited by 21
Vitamin E in renal therapeutic regimens
Thabet, M., & Chan, J. C. M. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0211-6 · Cited by 21
“A placebocontrolled trial noted that high doses of VE (1,800 IU/d) normalized renal hyperfiltration and abnormalities of retinal blood flow in patients with <10 years duration of type I DM [112].”
BackgroundChidambaram, K., & Mandal, S. C. (2007) · Medicinal Chemistry Research · doi:10.1007/s00044-007-9056-1 · Cited by 19
“However, antioxidant supplements or foods containing antioxidants may be used to help the human body reduce oxidative damage and decreases the occurrence of complications in diabetic animals (Bursell et al., 1999).”
Current and future pharmacological intervention for diabetic retinopathy
Comer, G. M., & Ciulla, T. A. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.441 · Cited by 19
Vitamin E and thetreatment and prevention of diabetes: a case for a controlled clinical trial.
Halliwell, B. B. (2002) · PubMed · Cited by 19
Ho, J.-I., Ng, E. Y., Chiew, Y., Koay, Y. Y., Chuar, P. F., Phang, S. C. W., Ahmad, B., & Kadir, K. A. (2022) · SAGE Open Medicine · doi:10.1177/20503121221095324 · Cited by 17
A Mediterranean Diet May Be Protective in the Development of Diabetic Retinopathy
Bryl, A., Mrugacz, M., Falkowski, M., & Zorena, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311145 · Cited by 23
“A Joslin Institute study demonstrated that in patients suffering from T1DM for less than 10 years, a dose of 1800 IU daily vitamin E improved retinal blood flow [98].”
BackgroundThe Role of Complementary and Alternative Therapies in Pediatric Diabetes
Shapiro, S., & Rapaport, R. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.09.004 · Cited by 16
Zhang, K., Ferreyra, H. A., Grob, S., Bedell, M., & Zhang, J. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00046-1 · Cited by 16
Latib, F., Zafendi, M. A. I., & Lazaldin, M. A. M. (2024) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2024.100224 · Cited by 16
Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats.
Mori, F., King, G. L., Clermont, A. C., et al. (2000) · PubMed · Cited by 15
Self-citationMedical Interventions for Diabetic Retinopathy
Richter, B., & KOHNER, E. M. (2005) · Evidence-Based Ophthalmology · doi:10.1002/9780470698709.ch42 · Cited by 16
MECHANISM OF DIABETIC NEPHROPATHY: ROLE OF PROTEIN KINASE-C ACTIVATION —
Ohshiro, Y., Lee, Y., & King, G. L. (2005) · Cited by 14
Self-citationTherapeutic Targets of Type 2 Diabetes: an Overview
Banu, S., & Bhowmick, A. (2017) · MOJ Drug Design Development & Therapy · doi:10.15406/mojddt.2017.01.00011 · Cited by 15
Iino, K., Iwase, M., Sonoki, K., et al. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00371.x · Cited by 14
Sympathetic sudomotor disturbance in early type 1 diabetes mellitus is linked to lipid peroxidation
Hoeldtke, R. D., Bryner, K. D., Hoeldtke, M. E., Christie, I., Ganser, G. H., Hobbs, G. R., & Riggs, J. E. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.023 · Cited by 14
Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Rusciano, D., & Bagnoli, P. (2023) · Medicina · doi:10.3390/medicina59071334 · Cited by 14
Effect of the Mediterranean Diet (MeDi) on the Progression of Retinal Disease: A Narrative Review
Sbai, O., Torrisi, F., Fabrizio, F. P., Rabbeni, G., & Perrone, L. (2024) · Nutrients · doi:10.3390/nu16183169 · Cited by 13
“Oral vitamin E treatment (1800 IU daily vitamin E) was effective in normalizing retinal hemodynamic abnormalities and enhancing renal function in T1DM patients [126].”
BackgroundSüleyman, H., Çinici, E., Ahiskali, I., Cetin, N., Süleyman, B., Kukula, O., Altuner, D., Çoban, T. A., Balta, H., & Kuzucu, M. (2016) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.187666 · Cited by 13
El-Harakeh, M. D., Njeim, R., Youssef, A. M., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.052 · Cited by 12
Yoshida, Y., Hayakawa, M., Cynshi, O., et al. (2008) · Journal of Oleo Science · doi:10.5650/jos.57.577 · Cited by 12
Oxidative Stress in Diabetic Retinopathy
Caldwell, R. B., El‐Remessy, A. B., & Caldwell, R. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_9 · Cited by 12
Metadata
- Authors
- Bursell, S. E., Clermont, A. C., Aiello, L. P., Aiello, L. M., Schlossman, D. K., Feener, E. P., Laffel, L., & King, G. L.
- Affiliations
- Joslin Diabetes Center (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1999-08-01
- Volume
- 22
- Issue
- 8
- Pages
- 1245-1251
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2027478328
- Cited by
- 333
- References
- 0
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 9 · 2021: 3 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 5 · 2015: 6 · 2014: 14 · 2013: 11 · 2012: 16
- FWCI
- 20.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- vitamin E supplementation, type 1 diabetes, retinal blood flow, retinal hemodynamics, creatinine clearance, renal function, diabetic nephropathy, diabetic retinopathy, glycemic control, HbA1c
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Creatinine, Diabetes Mellitus, Type 1, Diabetic Retinopathy, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Metabolic Clearance Rate, Middle Aged, Regional Blood Flow, Retinal Vessels, Vitamin E, Treatment Outcome, Plasminogen Activator Inhibitor 1, Cross-Over Studies, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review